Composition

Each tablet contains
S-Amlodipine nicotinate 3.253mg
(S-Amlodipine 2.5mg)

Indications

1. 2.5mg/5mg Hypertension, Chronic Stable Angina, Vasospastic Angina
   (Prinzmetal's or Variant Angina).
2. 5mg In patients recently diagnosed with CAHD by angiogram and with no heart failure or with
   more than 40% of cardiac output
   - reduce risk of hospitalization due to angina
   - reduce risk of coronary artery revascularization

Packing

30Tabs/PTP, 300Tabs/BTL

Shelf life

3 years

Composition

Each tablet contains
S-Amlodipine nicotinate 6.506mg
(S-Amlodipine 5mg)

Indications

1. 2.5mg/5mg: Hypertension, Chronic Stable Angina, Vasospastic Angina (Prinzmetal\'s or Variant Angina).
2. 5mg: In patients recently diagnosed with CAHD by angiogram
   and with no heart failure or with more than 40% of cardiac output
   - reduce risk of hospitalization due to angina
   - reduce risk of coronary artery revascularization

Packing

30Tabs/PTP
300Tabs/BTL

Shelf life

3 years

Composition

Each tablet contains
Sodium Risedronate 35mg
Cholecalciferol conc. 56mg(5,600 I.U.)

Indications

1. Treatment and prevention of postmenopausal
2. osteoporosis.
3. Treatment of osteoporosis in men.

Packing

4Tabs/PTP

Shelf life

3 years

Composition

Each tablet contains
Sodium Risedronate 150mg
Cholecalciferol 0.75mg(30,000 I.U.)

Indications

1. Treatment and prevention of postmenopausal
2. osteoporosis in women.

Packing

1Tab/PTP

Shelf life

3 years

Composition

Each mL contains
Mometasone furoate 0.5mg
Azelastine HCl 1.4mg

Indications

1. Perennial allergic rhinitis.

Packing

18mL

Shelf life

3 years

Composition

Each tablet contains
Bepotastine salicylate 9.64mg
(Bepotastine 7.11mg)

Indications

1. Perennial allergic rhinitis
2. Chronic urticarial
3. pruritus accompanied by skin diseases (eczema, dermatitis, skin itchiness, prurigo)

Packing

30Tabs/BTL
300Tabs/BTL

Shelf life

2 years

Composition

Each mL contains Cyclosporin 0.5mg

Indications

1. Increase tear production in patients whose tear production is presumed
      to be suppressed due to ocular inflammation associated with keratoconjunctivitis sicca

Packing

0.4mL x 30ea

Shelf life

2 years

Composition

Each tablet contains
S-Amlodipine 2.5mg
Olmesartan medoxomil 20mg

Indications

1. Essential hypertension in adult patients whose blood pressure is not adequately
       controlled on Amlodipine (S-Amlodipine) or olmesartan medoxomil monotherapy.

Packing

30Tabs/BTL
300Tabs/BT

Shelf life

3 years

Composition

Each tablet contains
S-Amlodipine 2.5mg
Olmesartan medoxomil 40mg

Indications

1. Essential hypertension in adult patients whose blood pressure is not adequately
      controlled on Amlodipine (S-Amlodipine) or olmesartan medoxomil monotherapy.

Packing

30Tabs/BTL
300Tabs/BT

Shelf life

3 years

Composition

Each tablet contains
S-Amlodipine 5mg
Olmesartan medoxomil 20mg

Indications

1. Essential hypertension in adult patients whose blood pressure is not adequately
       controlled on Amlodipine (S-Amlodipine) or olmesartan medoxomil monotherapy.

Packing

30Tabs/BTL
300Tabs/BT

Shelf life

3 years

Composition

Each tablet contains
S-Amlodipine 5mg
Olmesartan medoxomil 40mg

Indications

1. Essential hypertension in adult patients whose blood pressure is not adequately
      controlled on Amlodipine (S-Amlodipine) or olmesartan medoxomil monotherapy.

Packing

30Tabs/BTL
300Tabs/BTL

Shelf life

3 years

Composition

Each capsule contains Pitavastatin calcium 2mg, Fenofibrate 160mg

Indications

1. Treatment for complex-dyslipidemeia (or combined hyperlipidemia) patients
   with high risk for Coronary Heart Disease (CHD) whose LDL-Cholesterol level
   is adequately controlled by pitavastatin 2mg monotherapy, wihle their triglyceride
   level remains high and HDL-Cholesterol level remains low.

Packing

30Caps/PTP

Shelf life

3 years